Multicenter trial using multi-dose rituximab as induction and desensitization therapy for patients on the waiting list for kidney transplant with a positive donor specific crossmatch to a living donor

Trial Profile

Multicenter trial using multi-dose rituximab as induction and desensitization therapy for patients on the waiting list for kidney transplant with a positive donor specific crossmatch to a living donor

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 19 Oct 2015

At a glance

  • Drugs Rituximab (Primary)
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Oct 2009 Actual end date (Sep 2007) added as reported by ClinicalTrials.gov.
    • 20 Oct 2009 Actual end date (Sep 2007) added as reported by ClinicalTrials.gov.
    • 19 May 2008 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov record..
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top